Feedback / Questions
Rituxan (rituximab) - Roche
lixudebart (ALE.F02) - Alentis Therap
http://clinicaltrials.gov/ct2/show/NCT06047171
May 10, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next